Citation Impact
Citing Papers
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
2007 Standout
Fosfomycin
2016
Contrast Medium-Induced Acute Kidney Injury
2015 Standout
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
2005 StandoutNobel
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
1997 Standout
Osmotic Nephrosis: Acute Kidney Injury With Accumulation of Proximal Tubular Lysosomes Due to Administration of Exogenous Solutes
2008
Clinical Pharmacokinetics in Organ Transplant Patients
1989
Mechanistic review of drug-induced steatohepatitis
2015
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
2002 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Ochratoxin A: The Continuing Enigma
2005
Mycotoxins: Occurrence, toxicology, and exposure assessment
2013 Standout
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
2011
Survival in Recipients of Marginal Cadaveric Donor Kidneys Compared with Other Recipients and Wait-Listed Transplant Candidates
2001 Standout
Intravenous Fluids and Acute Kidney Injury
2017 Standout
Utilization of the older donor for renal transplantation
1996
Infection in Organ-Transplant Recipients
1998 Standout
Antibiotic Pharmacokinetics in Cystic Fibrosis
1987
Balkan endemic nephropathy: an update on its aetiology
2016
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Drug-induced vasculitides
1991
Ochratoxin A in human kidney diseases
2005
Acute effects of acetylsalicylic acid in patients with chronic renal insufficiency
1977
The application of statistical moment theory to the evaluation ofin vivo dissolution time and absorption time
1980 Standout
Endemic nephropathy: the case for chronic poisoning by aristolochia.
2005
Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses
1977
Correlation between renal membrane binding and nephrotoxicity of aminoglycosides
1987
Guanfacine
1986
The etiology of Balkan endemic nephropathy: still more questions than answers.
1998
Worldwide contamination of food-crops with mycotoxins: Validity of the widely cited ‘FAO estimate’ of 25%
2019 Standout
Acute effects of acetylsalicylic acid on renal function in normal man
1977
Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
1984 Standout
Agents that increase the permeability of the outer membrane
1992 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Works of Fillastre Jp being referenced
Nephrotoxicity of gentamicin. Action on subcellular organelles and pharmacokinetics in the kidney.
1978
Pharmacokinetics of cyclosporine A in patients with nephrotic syndrome.
1988
[Pharmacokinetic study of guanfacine in patients with renal insufficiency and in patients under chronic dialysis (author's transl)].
1980
Is ochratoxin a nephrotoxic in human beings?
1997
[Experimental and human nephrotoxicity induced by ochratoxins].
1997
[The effect of fosfomycin on the respiration of rat kidney motochondria].
1978
[Acute reversible renal insufficiency after prolonged treatment with dextran].
1967
Regenerating tubular cell process in rat kidney: influence of gentamicin treatment.
1987
Pharmacokinetics of azlocillin in healthy subjects.
1981
Changes in the lysosomes and mitochondria isolated from the liver, kidney and heart of rats treated with perhexiline maleate.
1982
[Changes in glomerular clearances and P.A.H. clearance after intravenous acetylsalicylic acid administration].
1973
Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.
1974
[Hypersensitivity vasculitis of drug origin].
1986
Thrombotic microangiopathy (TMA) as the first manifestation of HIV infection.
1993